Related Experiment Video
Updated: Jul 13, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
The Prognostic Value of Creatine Kinase-MB Dynamics after Primary Angioplasty in ST-Elevation Myocardial Infarctions
Delia Melania Popa1, Liviu Macovei1,2, Mihaela Moscalu3
1Cardiology Department, Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Iași, Romania.
Insights
Creatine Kinase-MB (CK-MB) levels in ST-elevation myocardial infarction (STEMI) patients predict short-term outcomes. Higher CK-MB levels correlate with reduced ejection fraction and increased mortality risk, aiding in complication prediction.
Area of Science:
- Cardiology
- Biomarkers
- Myocardial Injury
Background:
- The prognostic value of myocardial injury biomarkers in ST-elevation myocardial infarction (STEMI) requires further investigation.
- While elevated creatine kinase-MB (CK-MB) is linked to mortality in STEMI patients undergoing angioplasty, its short-term prognostic implications are not fully understood.
Purpose of the Study:
- To evaluate the relationship between CK-MB levels and short-term prognoses in STEMI patients.
- To determine the predictive value of CK-MB for complications and mortality following STEMI.
Main Methods:
- Retrospective analysis of data from 80 STEMI patients.
- Categorization into groups based on acute complications and mortality.
- Assessment of CK-MB levels upon admission, peak levels, and variation.
Main Results:
- Elevated admission and peak CK-MB levels correlated with decreased left ventricular ejection fraction.
- CK-MB variation predicted complications with a threshold of 388 U/L.
- A CK-MB cut-off of 354 U/L predicted mortality.
Conclusions:
- CK-MB levels serve as reliable indicators for STEMI patient outcomes.
- The difference between peak and admission CK-MB levels accurately predicts complications.
- CK-MB variation demonstrates significant predictive power for mortality risk in STEMI.
Background:
In STEMIs, the evaluation of the relationship between biomarkers of myocardial injury and patients' prognoses has not been completely explored. Increased levels of CK-MB in patients with a STEMI undergoing primary angioplasty are known to be associated with higher mortality rates, yet the correlation of these values with short-term evolution remains unknown.
Material And Methods:
The research encompassed a sample of 80 patients diagnosed with STEMIs, and its methodology entailed a retrospective analysis of the data collected during their hospital stays. The study population was then categorized into three distinct analysis groups based on the occurrence or absence of acute complications and fatalities.
Results:
The findings indicated that there is a notable correlation between rising levels of CK-MB upon admission and peak CK-MB levels with a reduction in left ventricular ejection fraction. Moreover, the CK-MB variation established a point of reference for anticipating complications at 388 U/L, and a cut-off value for predicting death at 354 U/L.
Conclusion:
CK-MB values are reliable indicators of the progress of patients with STEMIs. Furthermore, the difference between the peak and admission CK-MB levels demonstrates a high accuracy of predicting complications and has a significant predictive power to estimate mortality risk.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations